Arbor launches sub-$100 monthly GLP-1 weight-loss injections with 48-hour delivery
Arbor's tele-health service now provides compounded GLP-1 weight-loss injections for under $100 a month, shipped within 48 hours and backed by a refund guarantee.
Arbor, a tele-health platform, now offers compounded GLP-1 weight-loss medications that can be prescribed by board-certified U.S. physicians after a 90-second online quiz and a ten-minute health assessment. Customers can choose semaglutide for $99 per month or tirzepatide for $149 per month, both delivered as weekly at-home injections with free FedEx shipping and an expected delivery window of 48 hours after approval. The service includes a money-back guarantee if users do not achieve their weight-loss targets, and it reports a 94.6% success rate among more than 10,000 patients.
In addition to medication, Arbor provides access to a dietitian for personalized nutrition plans, a direct-chat line for urgent questions, and transition support when discontinuing GLP-1 therapy. Plans are HSA/FSA eligible and can be cancelled at any time. Compounded drugs are not FDA-reviewed, and provider eligibility varies by state.
Why it matters
It expands affordable, rapid access to GLP-1 weight-loss drugs, influencing both consumer health options and the pharmaceutical market.
In this story
